Skip to main content

CAC-2 Systemic corticosteroids for Inpatient Asthma

CBE ID
0144
Endorsement Status
1.1 New or Maintenance
Previous Endorsement Cycle
Is Under Review
No
1.3 Measure Description

Use of systemic corticosteroids in pediatric asthma patients (age 2 through 17 years) admitted for inpatient treatment of asthma. This measure is a part of a set of three nationally implemented measures that address children’s asthma care (CAC-1: Relievers for Inpatient Asthma, CAC-3: Home Management Plan of Care (HMPC) Document Given to Parent/Caregiver) that are used in The Joint Commission’s accreditation process.

        • 1.14 Numerator

          Pediatric asthma inpatients who received systemic corticosteroids during hospitalization.

        • 1.15 Denominator

          Pediatric asthma inpatients (age 2 years through 17 years) who were discharged with a principal diagnosis of asthma.

        • Exclusions

          Excluded Populations:
          • Patients with an age less than 2 years or 18 years or greater
          • Patients who have a Length of Stay greater than 120 days
          • Patients enrolled in clinical trials
          • Patients with a documented Reason for Not Administering Systemic Corticosteroids

        • Most Recent Endorsement Activity
          Measure Retired and Endorsement Removed Pulmonary Endorsement Maintenance Project
          Initial Endorsement
          Last Updated
          Removal Date
        • Steward
          The Joint Commission
          Steward Organization POC Email
          Steward Organization Copyright

          The Specifications Manual for National Hospital Inpatient Quality Measures Version 4.0, January, 2012 is the collaborative work of the Centers for Medicare & Medicaid Services and The Joint Commission. The Specifications Manual is periodically updated by the Centers for Medicare & Medicaid Services and The Joint Commission. Users of the Specifications Manual for National Hospital Inpatient Quality Measures must update their software and associated documentation based on the published manual production timelines.
          No royalty or use fee is required for copying or reprinting this manual, but the following are required as a condition of usage: 1) disclosure that the Specifications Manual is periodically updated, and that the version being copied or reprinted may not be up-to-date when used unless the copier or printer has verified the version to be up-to-date and affirms that, and 2) users participating in the QIO supported initiatives, the Hospital Inpatient Quality Reporting Program, and Joint Commission accreditation; including performance measures systems; are required to update their software and associated documentation based on the published manual production timelines.